Today, Explained – "The End of Dieting" (Nov 11, 2025)

Main Theme and Purpose

This episode of Today, Explained explores how the conversation around weight loss and obesity has transformed in the United States, especially with the rise of new, highly effective weight loss drugs like Mounjaro and Ozempic. Host Noel King, joined by writer and editor Sumita Mukapadai and endocrinologist Dr. Dan Bessason, unpacks the personal, cultural, and medical implications of moving from traditional dieting and exercise to pharmaceutical interventions. The episode questions whether we have reached ‘the end of dieting’ as we knew it, and what that means for individuals and society.

Key Discussion Points and Insights

President Trump’s Weight Loss Drug Announcement

• Timestamps: 01:06–01:40
  • Recent political news: President Trump announced a deal to make weight loss drugs more affordable, revealing members of his administration—including his head of PR—are taking these drugs.
  • The drugs appear effective, and US obesity rates are declining, but there are still many unknowns regarding long-term health.

Sumita Mukapadai’s Personal Journey with Weight, Dieting, and Medication

• Timestamps: 02:10–12:31

• Entering the Fashion Industry (02:33)

  • Sumita describes joining Teen Vogue during a shift toward acceptance and advocacy for diverse body types.
  • Quote: "There was an increased interest in plus fashion...How does it feel to be a fat fashion editor?" (Sumita, 02:33)

• Personal Health Turning Point

  • A series of family tragedies (father’s death from diabetes, mother's cancer diagnosis, stressful job) led to stress eating, weight gain, and notable health/mobility issues.
  • Initial medical assessment showed prediabetes and high cholesterol.

• Decision to Try Mounjaro (05:48)

  • Emotional struggle: Conflict between body positivity beliefs and the need to address serious health issues.
  • Quote: "I saw it as a betrayal to the kind of body positivity and feminism that I had ascribed to...And also there was another voice inside me that was like, this is how bad it's gotten, girl." (Sumita, 06:15)

• Physical and Emotional Effects

  • Difficult side effects: intense nausea and severe constipation requiring additional medications. Sumita notes these never entirely faded.
  • Quote: "Physically, it is a bumpy road. It was for me...It is very hard to go to the bathroom when you're on it." (Sumita, 06:15)
  • The drug successfully reduced compulsive evening eating and made ‘healthy choices’ far easier.

• The Cost Barrier and Aftermath

  • Mounjaro was affordable due to a manufacturer's coupon, but after it ended, monthly costs skyrocketed to $600–800, prompting Sumita to stop.
  • Quote: "Overnight the drug becomes six to eight hundred dollars a month...That's crazy." (Sumita, 09:44)
  • She lost about 50 pounds, maintained it for several months after quitting, but regaining weight has been emotionally difficult.
  • Quote: "It’s been a roller coaster...the high of like, oh, like the weight came off and then to like, be feel like I’m back to square one. Even though I know in my mind and my heart and my spirit, I am not." (Sumita, 12:28)

The Medical and Historical Context of Dieting and Obesity

• Dr. Dan Bessason, Endocrinologist (16:08–27:01)

• Obesity as a Medical Problem (16:48)

  • Serious medical concern emerged in national consciousness in the late '80s–mid '90s, with focus ramping up after NIH and CDC began tracking obesity via BMI.

• Early Medical Strategies (18:29)

  • Initial interventions centered on:
    • Diet and exercise for mild cases
    • Medication for moderate cases
    • Surgery for severe cases
  • At the time, little was known about the biology of weight regulation; the advice was to "eat less and move more."

• Effectiveness of Diet and Exercise (19:51–21:22)

  • Clinical studies show a modest (5%) weight loss can significantly reduce diabetes risk—but most people regain much of the lost weight over time.
  • Quote: "[Most] lifestyle studies show that most people regain much of the weight...The biology of weight really pushes back against efforts to change our diet." (Dr. Dan, 21:22)

• Medications and Stigma

  • Early weight loss drugs (like fen phen) were rarely prescribed due to safety concerns and societal attitudes—doctors believed patients should lose weight on their own.
  • Quote: "Doctors would say things like, you know, if you show me you can stick to a diet, well, then I'll maybe talk to you about a medicine. We don't do that with diabetes or high blood pressure." (Dr. Dan, 23:12)
  • Only about 1–2% of patients had weight loss medications prescribed 20 years ago.

• The Advent of Modern GLP-1 Drugs (Ozempic, Mounjaro, etc.) (24:30)

  • Dr. Bessason calls these drugs a "game changer," producing weight loss akin to bariatric surgery.
  • Over 100 new anti-obesity medications are in development, some even more effective than current offerings.
  • These drugs have transformed not just medical potential, but what it means to live with and treat obesity.

• Unexpected Impacts of Medication

  • Profound changes in physiological hunger—and thus, relationship to food and social dynamics—aren’t always anticipated by patients.
  • Quote: "What does your life look like when you're not interested in food?...It makes changes in people's relationships with other folks." (Dr. Dan, 25:18)
  • The landscape is chaotic, with demand high, patients sometimes ill-prepared, and little social infrastructure for these changes.
  • Key message: weight is biologically regulated, and obesity treatment is a journey that ideally involves collaboration with a healthcare professional.

Notable Quotes and Memorable Moments

• "I really wanted a strategy that would be more effective. And so I went in and got my blood work done...I was prediabetic. My cholesterol was elevated. And so those scared me."
  —Sumita Mukapadai (04:24)

• "It really gave me this release from this yearning that I always had...with the kind of pharmaceutical intervention, I was able to stop."
  —Sumita Mukapadai (08:34)

• "We tend to blame [patients] for their health problem. So medicines that weren't super effective and an environment that really thought that people could do this on their own."
  —Dr. Dan Bessason (23:53)

• "There’s never been anything like [these new drugs]...medications are likely to provide the kind of weight loss that we used to only see with bariatric surgery."
  —Dr. Dan Bessason (24:30)

• "It's a bit of a chaotic environment. I think the key message I'd ask people to understand is this idea that weight is biologically regulated...it's a journey."
  —Dr. Dan Bessason (26:30)

Important Timestamps

• 01:06–01:40: Context of President Trump’s weight loss drug announcement
• 02:33–06:06: Sumita Mukapadai’s entry into fashion, personal health challenges, and decision to try weight-loss medication
• 06:06–09:26: Experience taking Mounjaro—struggles with shame, stigma, and side effects
• 09:26–12:31: The high cost of medication, transitioning off Mounjaro, emotional toll of weight regain
• 16:08–19:51: Dr. Dan Bessason on how obesity became a medical crisis and early approaches
• 19:51–21:22: Effectiveness and limitations of diet and exercise
• 22:20–24:30: Medications and shifting perspectives in medical treatment
• 24:30–27:01: The impact of new drugs like Ozempic on patients, the medical system, and society

Conclusion

This episode draws a nuanced picture of a society at a crossroads: as groundbreaking drugs make lasting weight loss possible for millions, the biological, personal, and social complexities of obesity and health remain. The guests highlight the hope these treatments bring, while honestly detailing their costs—financial, physical, and emotional—and the continuing need for supportive, well-informed care.

For listeners, the takeaway:
The end of traditional dieting isn't just about new drugs—it's about rethinking blame, biology, and what real support looks like in the journey to health.